Manila Times Business
sweelin® Clinical Trial Results Published in Leading Journal, Food Chemistry, Confirming Blood Glucose Safety
This world's first clinical study on sweet proteins, reflects the clinical relevance of Amai Protein's sweelin®. The double-blind, randomized, crossover clinical study confirmed that sweelin® does not affect blood glucose, insulin and GLP-1 levels compared to stevia and dextrose in healthy adults. sweelin® is a next-generation sweet protein that enables significant sugar reduction and replaces conventional sweeteners with a protein-based alternative, designed to deliver superior clean taste, com
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
DEMIRE: Major shareholders launch structured sale process
Just now
AMAYA BIG SKY CAPITAL ANNOUNCES RESIGNATION OF DIRECTOR
Just now
Fairfax Announces Acquisition of Additional Orla Mining Ltd. Common Shares
Just now
Nocera Inc. (Nasdaq:NCRA) Advances AI and Acquisition Strategy Through Binding Venture Platform Agreement with U.S.-Based Digital Innovations Group
Just now